MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the company’s chairman and CEO, Gary Rabin, will be presenting at Roth Capital Partners’ 24th Annual ROTH Conference, March 11-14.
Mr. Rabin’s presentation will take place on Wednesday, March 14, at 12:00PM PDT at the Ritz Carlton Laguna Niguel, Salon 2, in Dana Point, Calif. The presentation slide deck will be available on the Conference Presentations section of the ACT website and the webcast of the presentation will be available via the following link: http://wsw.com/webcast/roth26/actc.ob/.
Roth Capital Partners plans to host more than 400 growth companies at its 24th annual investment conference, March 11-14, including more than 130 healthcare companies in the biotechnology, healthcare services, medical device, and pharmaceutical sectors.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com. |
